These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19627901)

  • 21. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower extremity fracture prevention and management in persons with spinal cord injuries and disorders: The patient perspective.
    Etingen B; Carbone LD; Guihan M; Ray C; Aslam H; Elam R; Weaver FM
    J Spinal Cord Med; 2022 Nov; 45(6):946-956. PubMed ID: 33830880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific.
    Korthoewer D; Chandran M;
    Arch Osteoporos; 2012; 7():193-200. PubMed ID: 23225297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pulse survey: assessment and management of bone loss in spinal cord injury.
    Dionyssiotis Y; Marshall R; Stillman MD; Morse LR; Rapidi AC
    Spinal Cord Ser Cases; 2021 Feb; 7(1):12. PubMed ID: 33574217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study.
    Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2015 Sep; 26(9):2273-80. PubMed ID: 25939310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive Sublesional Bone Loss Extends into the Second Decade After Spinal Cord Injury.
    Cirnigliaro CM; Myslinski MJ; Asselin P; Hobson JC; Specht A; La Fountaine MF; Kirshblum SC; Forrest GF; Dyson-Hudson T; Spungen AM; Bauman WA
    J Clin Densitom; 2019; 22(2):185-194. PubMed ID: 30503961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of risk and use of prophylaxis for glucocorticoidinduced-osteoporosis among dermatologists in the Pacific Northwest: a survey study.
    Notaro E; Fett N; Shinohara MM
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reasons for Not Treating Women with Postmenopausal Osteoporosis with Prescription Medications: Physicians' and Patients' Perspectives.
    Weaver JP; Olsson K; Sadasivan R; Modi A; Sen S
    J Womens Health (Larchmt); 2017 Dec; 26(12):1302-1311. PubMed ID: 28994642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of drugs on bone metabolism in a cohort of individuals with traumatic spinal cord injury.
    Kokorelis C; Gonzalez-Fernandez M; Morgan M; Sadowsky C
    Spinal Cord Ser Cases; 2019; 5():3. PubMed ID: 30675387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mass in individuals with chronic spinal cord injury: associations with activity-based therapy, neurologic and functional status, a retrospective study.
    Hammond ER; Metcalf HM; McDonald JW; Sadowsky CL
    Arch Phys Med Rehabil; 2014 Dec; 95(12):2342-9. PubMed ID: 25083557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.
    Duyvendak M; Naunton M; van Roon EN; Brouwers JR
    J Clin Pharm Ther; 2011 Jun; 36(3):356-66. PubMed ID: 21545615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone Mineral Density Testing in Spinal Cord Injury: 2019 ISCD Official Position.
    Morse LR; Biering-Soerensen F; Carbone LD; Cervinka T; Cirnigliaro CM; Johnston TE; Liu N; Troy KL; Weaver FM; Shuhart C; Craven BC
    J Clin Densitom; 2019; 22(4):554-566. PubMed ID: 31501005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Gifre L; Ruiz-Gaspà S; Carrasco JL; Portell E; Vidal J; Muxi A; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2017 Sep; 28(9):2707-2715. PubMed ID: 28580511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
    Naik-Panvelkar P; Norman S; Elgebaly Z; Elliott J; Pollack A; Thistlethwaite J; Weston C; Seibel MJ
    BMC Fam Pract; 2020 Feb; 21(1):32. PubMed ID: 32050909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment of osteoporosis after SCI: promising research, but not yet indicated.
    Anderson D; Park AJ
    Spinal Cord Ser Cases; 2019; 5():25. PubMed ID: 31666986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing practice pattern differences in the treatment of acute low back pain in the United States Military Health System.
    Dietrich EJ; Leroux T; Santiago CF; Helgeson MD; Richard P; Koehlmoos TP
    BMC Health Serv Res; 2018 Sep; 18(1):720. PubMed ID: 30223830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Primary Care Provider's Guide to Bone Health in Spinal Cord-Related Paralysis.
    Sadowsky CL; Mingioni N; Zinski J
    Top Spinal Cord Inj Rehabil; 2020; 26(2):128-133. PubMed ID: 32760192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
    Angthong C; Rodjanawijitkul S; Samart S; Angthong W
    Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.